Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

View:
Post by subaru1 on Sep 08, 2021 11:21am

Ceo

Any comments why it takes so long to find a new CEO. I think that until we get a new CEO with a good plan the stock wil not move.
Comment by corvette67 on Sep 08, 2021 12:55pm
Probably because it appears to be "TOAST'. GLTA
Comment by checkup on Sep 09, 2021 4:40pm
This post has been removed in accordance with Community Policy
Comment by Righttothetop on Sep 14, 2021 8:57am
My spidey sense is telling me that a pennies on the dollar takeout is imminent.  Many of the things line up really...CEO competition taking forever, Taves stepping in as Board Chair, no real movement on any other international deals or guidance. Trust me when I say I wouldn't like this one bit.....but I think it's going to happen pre-Xmas unfortunately.  Given what this ...more  
Comment by Lemoyne on Sep 15, 2021 10:49am
A take out would be a surprise to me, but at this point, anything is possible. IMO, I think the appointment of Taves as the chairman of the board is to prepare the arrival of a decent CEO. The chair of the board reflects a big slice of the company leadership. ie, I doubt any respectable high potential CEO would of been interested in LABS with Pat as chair of the board. Having someone with solid ...more  
Comment by Righttothetop on Sep 16, 2021 12:50pm
I think a takeout because Taves is the new chair is exactly why it's likely.  He's a super capital markets poobah with (undoubtedly) significant M&A chops and therefore can act as proper governance to oversee whoever they stick in as figure head CEO. I'm hoping you're right of course and this just means that a well-respected experienced pharma person is on the front ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities